MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-26-2026
Microbot Medical Operating Income 2011-2026 | MBOT
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Microbot Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14.7 M | -11.6 M | -9.86 M | -13.3 M | -11.4 M | -9.09 M | -7.24 M | -7.24 M | 5.27 M | -9.64 M | 915 K | -1.09 M | -28.1 M | -21.9 M | -28.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.27 M | -28.1 M | -11.1 M |
Quarterly Operating Income Microbot Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.86 M | -3.72 M | -3.02 M | - | -3.3 M | -2.51 M | -2.38 M | - | -2.54 M | -2.32 M | -2.92 M | - | -3.47 M | -3.56 M | -3.18 M | - | -2.55 M | -2.48 M | -2.39 M | - | -2.42 M | -1.88 M | -2.16 M | - | -1.79 M | -1.54 M | -1.92 M | - | -1.75 M | -1.89 M | -1.52 M | - | -1.24 M | -1.26 M | -1.23 M | - | -645 K | 118 K | 285 K | - | -29.7 K | -9.27 M | -8.96 M | - | -6.38 M | -7.96 M | -6.84 M | - | -6.66 M | -6.22 M | -6.26 M | - | -5.08 M | -5.35 M | -5.33 M | - | -6.16 M | -7.09 M | -7.51 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 285 K | -9.27 M | -3.56 M |
Operating Income of other stocks in the Medical instruments industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
683 M | $ 70.29 | 0.17 % | $ 14 B |  USA |
 |
Atrion Corporation
ATRI
|
22.6 K | - | - | $ 810 M | USA |
 |
Alcon
ALC
|
580 M | $ 74.63 | 0.09 % | $ 40.4 B |  Schweiz |
 |
Baxter International
BAX
|
-308 M | $ 16.65 | -0.18 % | $ 8.54 B | USA |
 |
BioLife Solutions
BLFS
|
-7.13 M | $ 19.27 | -1.23 % | $ 888 M | USA |
 |
AtriCure
ATRC
|
-9.45 M | $ 29.19 | 0.41 % | $ 1.39 B | USA |
 |
electroCore
ECOR
|
-13.2 M | $ 7.04 | 3.53 % | $ 59.7 K | USA |
 |
Ekso Bionics Holdings
EKSO
|
-13.3 M | $ 9.75 | 3.72 % | $ 23.7 M | USA |
 |
Glaukos Corporation
GKOS
|
-129 M | $ 116.69 | 3.48 % | $ 5.65 B | USA |
 |
Haemonetics Corporation
HAE
|
222 M | $ 58.46 | 2.87 % | $ 2.94 B | USA |
 |
Harvard Bioscience
HBIO
|
-48.6 M | $ 5.53 | 6.35 % | $ 245 M | USA |
 |
ICU Medical
ICUI
|
42.8 M | $ 122.99 | -0.26 % | $ 3.03 B | USA |
 |
InfuSystem Holdings
INFU
|
1.65 M | $ 9.43 | 1.51 % | $ 195 M | USA |
 |
iRhythm Technologies
IRTC
|
-57.4 M | $ 117.22 | 0.36 % | $ 3.75 B | USA |
 |
Isoray
ISR
|
-114 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
2.95 B | $ 452.58 | 0.11 % | $ 162 B | USA |
 |
Repro Med Systems
KRMD
|
-2.97 M | $ 4.26 | -1.39 % | $ 197 M | USA |
 |
LeMaitre Vascular
LMAT
|
67.9 M | $ 109.16 | 0.62 % | $ 2.47 B | USA |
 |
Masimo Corporation
MASI
|
-267 M | $ 178.49 | -0.06 % | $ 9.51 B | USA |
 |
Milestone Scientific
MLSS
|
-5.7 M | $ 0.29 | 1.9 % | $ 23.8 M | USA |
 |
Merit Medical Systems
MMSI
|
185 M | $ 67.81 | 0.16 % | $ 4.01 B | USA |
 |
Envista Holdings Corporation
NVST
|
216 M | $ 25.81 | - | $ 4.34 B | USA |
 |
Predictive Oncology
POAI
|
-181 M | - | - | $ 31.1 M | USA |
 |
Pro-Dex
PDEX
|
10.7 M | $ 48.53 | -6.08 % | $ 160 M | USA |
 |
Pulse Biosciences
PLSE
|
-76.9 M | $ 22.94 | -0.26 % | $ 1.55 B | USA |
 |
ResMed
RMD
|
1 B | $ 224.93 | 0.37 % | $ 32.9 B | USA |
 |
Retractable Technologies
RVP
|
-21.2 M | $ 0.71 | 2.98 % | $ 21.3 M | USA |
 |
NeuroMetrix
NURO
|
-8.78 M | - | 5.05 % | $ 9.02 M | USA |
 |
STAAR Surgical Company
STAA
|
-91.7 M | $ 20.96 | 3.71 % | $ 1.04 B | USA |
 |
STERIS plc
STE
|
867 M | $ 219.97 | 0.58 % | $ 21.7 B | USA |
 |
Stereotaxis
STXS
|
-22.1 M | $ 1.88 | -0.53 % | $ 171 M | USA |
 |
Teleflex Incorporated
TFX
|
13.9 M | $ 115.04 | -2.35 % | $ 5.13 B | USA |
 |
Utah Medical Products
UTMD
|
11.4 M | $ 62.93 | -0.3 % | $ 204 M | USA |
 |
West Pharmaceutical Services
WST
|
585 M | $ 256.85 | 0.8 % | $ 18.6 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-422 M | $ 11.64 | 0.09 % | $ 2.32 B | USA |
 |
AngioDynamics
ANGO
|
-40 M | $ 9.84 | -4.56 % | $ 402 M | USA |
 |
Becton, Dickinson and Company
BDX
|
2.58 B | $ 155.32 | 0.52 % | $ 44.7 B | USA |
 |
Nephros
NEPH
|
-1.59 M | $ 2.86 | -0.35 % | $ 29.7 M | USA |
 |
OraSure Technologies
OSUR
|
-72 M | $ 3.08 | - | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
47.7 M | $ 116.95 | -0.7 % | $ 6.52 M | USA |